Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 291

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Clonogenic assay with established human tumour xenografts

Fiebig, H.H, Maier, A, Burger, A.M·2004·European Journal of Cancer
DOI 10.1016/j.ejca.2004.01.009
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejca.2004.01.009

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 42

  1. Ferguson, 1989, Phenotypic instability of drug sensitivity in a human colon carcinoma cell line, Cancer Res., 49, 1148
  2. Smith, 1989, Sequential cytogenetic studies in an ovarian cancer cell line, Cancer Genet. Cytogenet., 38, 13, 10.1016/0165-4608(89)90160-X · doi:10.1016/0165-4608(89)90160-x
  3. Fiebig, 1987, Colony assay with human tumor xenografts, murine tumors and human bone marrow. Potential for anticancer drug development, Eur. J. Cancer Clin. Oncol., 23, 937, 10.1016/0277-5379(87)90339-7 · doi:10.1016/0277-5379(87)90339-7
  4. Salmon, 1984, Human tumor colony assay and chemosensitivity testing, Cancer Treat Rep., 68, 117
  5. Schlunk, 1980, The influence of culture conditions on the production of colony-stimulating activity by human placenta, Exp. Hematol., 8, 179
  6. Gallacher, 2000, Identification of novel circulating human embryonic blood stem cells, Blood, 96, 1740, 10.1182/blood.V96.5.1740 · doi:10.1182/blood.v96.5.1740
  7. Fiebig HH, Berger DP, Dengler WA, Wallbrecher E, Winterhalter BR. Combined in vitro/in vivo test procedure with human tumor xenografts for new drug development. In Fiebig HH, Berger DP, eds. Immunodeficient Mice in Oncology. Contrib Oncol Basel, Karger, 1992, 42, 321–351. · doi:10.1159/000421298
  8. Maurer, 1981, Tumor stem cell cloning in agar-containing capillaries, Naturwissenschaften, 68, 381, 10.1007/BF01058036 · doi:10.1007/bf01058036
  9. Hanauske, 1988, Recombinant human transforming growth factor-alpha stimulates in vitro colony formation of fresh human tumor specimens, Int. J. Cell Cloning, 6, 221, 10.1002/stem.5530060307 · doi:10.1002/stem.5530060307
  10. Bertelsen, 1984, Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations, Cancer, 53, 1240, 10.1002/1097-0142(19840315)53:6<1240::AID-CNCR2820530604>3.0.CO;2-Y · doi:10.1002/1097-0142(19840315)53:6<1240::aid-cncr2820530604>3.0.co;2-y
  11. Carmichael, 1987, Evaluation of a tetrazolium-based semiautomated colometric assay, Cancer Res., 47, 936
  12. Hoffman, 1991, Three-dimensional histoculture, Cancer Cells, 3, 86
  13. Inaba, 1996, In vitro-in vivo correlation in anticancer drug sensitivity test using AUC-based concentrations and collagen gel-droplet-embedded culture, Oncology, 53, 250, 10.1159/000227569 · doi:10.1159/000227569
  14. Sevin, 1988, Application of an ATP-bioluminescense assay in human tumor chemosensitivty testing, Gynecol. Oncol., 31, 191, 10.1016/0090-8258(88)90293-4 · doi:10.1016/0090-8258(88)90293-4
  15. Lieber, 1981, Anticancer drug testing in vitro, Life Sciences, 28, 287, 10.1016/0024-3205(81)90735-9 · doi:10.1016/0024-3205(81)90735-9
  16. Link, 1996, Regional chemotherapy directed by individual chemosensitivity testing in vitro, Clin. Cancer Res., 2, 1469
  17. Link, 2000, Thymidylate synthase quantitation and in vitro chemosensitivity testing predicts responses and survival of patients with isolated nonresectable liver tumors receiving hepatic arterial infusion chemotherapy, Cancer, 89, 288, 10.1002/1097-0142(20000715)89:2<288::AID-CNCR13>3.0.CO;2-O · doi:10.1002/1097-0142(20000715)89:2<288::aid-cncr13>3.0.co;2-o
  18. Grever, 1992, The National Cancer Institute, Semin. Oncol., 19, 622
  19. Shoemaker, 1985, Application of a human tumor colony-forming assay to new drug screening, Cancer Res., 45, 2145
  20. Berger, 1989, Quality control measures in the clonogenic assay, Proc. Am. Ass. Cancer Res., 30, 610
  21. Thomson, 1984, Kinetics of clonogenic melanoma cell proliferation and the limits of growth within a bilayer agar system, J. Cell. Physiol., 121, 114, 10.1002/jcp.1041210114 · doi:10.1002/jcp.1041210114
  22. Alley, 1982, Improved detection of drug cytotoxicity in the soft agar colony formation assay through use of a metabolizable tetrazolium salt, Life Sci., 31, 3071, 10.1016/0024-3205(82)90077-7 · doi:10.1016/0024-3205(82)90077-7
  23. Berger DP, Fiebig HH, Winterhalter BR. Establishment and characterization of human tumor xenograft models in nude mice. In. Fiebig HH, Berger DP, eds. Immunodeficient Mice in Oncology. Contrib Oncol Basel, Karger, 1992, 42, 23–46. · doi:10.1159/000421257
  24. Selby, 1983, A critical appraisal of the “human tumor stem cell assay”, N. Engl. J. Med., 308, 129, 10.1056/NEJM198301203080304 · doi:10.1056/nejm198301203080304
  25. Phillips RM. In vitro models of solid-tumour biology and drug delivery: Implications for and applications to target-oriented screening for novel anticancer drugs. Fiebig HH, Burger AM, eds. Relevance of Tumor Models for Anticancer Drug Development. Contrib Oncol Basel, Karger, 1999, 54, 67–80. · doi:10.1159/000425823
  26. Phillips, 2003, Three dimensional cellular models and hypoxia selective toxins, Onkologie, 26, 390
  27. Wirth, 2003, Xenograft tissue microarrays, Onkologie, 26, 388
  28. Kelter, 2003, A cellular high throughput screen for anticancer drug discovery, Onkologie, 26, 389
  29. Plowmann J, Camalier R, Alley M, Sausville E, Schepartz S. US-NCI Testing procedures. In Fiebig HH, Burger AM, eds. Relevance of Tumor Models for Anticancer Drug Development. Contrib Oncol Basel, Karger, 1999, 54, 121–135. · doi:10.1159/000425828
  30. Smith, 2003, 17-DMA-Geldanamycin is a novel water-soluble, orally bioavailable Hsp90 inhibitor with potent in vitro and in vivo anticancer activity, Proc. Am. Assoc. Cancer Res., 44, 153
  31. Smith, 2003, Modulators of heat shock protein 90 –– targeting multiple signal transduction pathways, Onkologie, 26, 386
  32. Jones, 1995, Randomized comparison of vinorelbine and melphalan in anthracycline-refractory advanced breast cancer, J. Clin. Oncol., 13, 2567, 10.1200/JCO.1995.13.10.2567 · doi:10.1200/jco.1995.13.10.2567
  33. Morris, 1998, Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix, J. Clin. Oncol., 16, 1094, 10.1200/JCO.1998.16.3.1094 · doi:10.1200/jco.1998.16.3.1094
  34. Maier, 2003, Antitumor activity of CYC202, a cyclin dependent kinase inhibitor, in human tumor xenografts in vitro, Proc. Am. Assoc. Cancer Res., 44, 619
  35. Burger, 2001, Antitumor activity of an aqueous mistletoe extract (AME) standardized for ML-1 in human tumor cell lines and xenografts in vitro, Drug Res., 51, 748
  36. Sharma, 2003, Outcome of ATP-based tumor chemosensitivity assay directed chemotherapy in heavily pre-treated recurrent ovarian carcinoma, BMC Cancer, 3, 19, 10.1186/1471-2407-3-19 · doi:10.1186/1471-2407-3-19
  37. Bertelsen, 1983, Heterogeneity of human metastatic clones by in vitro chemosensitivity testing, Arch. Surg., 118, 1406, 10.1001/archsurg.1983.01390120036010 · doi:10.1001/archsurg.1983.01390120036010
  38. Kern, 1998, Heterogeneity of drug resistance in human breast and ovarian cancers, Cancer J. Sci. Am., 4, 41
  39. Drees, 1997, Flavopiridol (L86-8275), Clin. Cancer Res., 3, 273
  40. Fiebig, 1994, Cyanocyclin A and the quinocarmycin analog NSC 607097 demonstrate selectivity against melanoma xenografts in vitro and in vivo, Proc. Am. Assoc. Cancer Res., 35, 468
  41. Winterhalter, 1993, High antitumor activity of rhizoxin in a combined in vitro and in vivo test procedure with human tumor xenografts, Proc. Am. Assoc. Cancer Res., 34, 376
  42. Burger, 1999, Recombinant mistletoe lectin (rML) is a potent inhibitor of tumor cell growth in vitro and in vivo, Proc. Am. Assoc. Cancer Res., 40, 399

Cited by

See all 291

Metadata

Authors
Fiebig, H. H., Maier, A., & Burger, A. M.
Venue
European Journal of Cancer
Publisher
Elsevier BV
Published
2004-04
Volume
40
Issue
6
Pages
802-820
ISSN
0959-8049 (ISSN-L)
DOI
10.1016/j.ejca.2004.01.009
OpenAlex
W54649336
Cited by
291
References
40
FWCI
4.55
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clonogenic assay with established human tumour xenografts. https://app.cochat.ai/papers/10.1016/j.ejca.2004.01.009
The paper
Fiebig, H. H., Maier, A., & Burger, A. M. (2004). Clonogenic assay with established human tumour xenografts. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2004.01.009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.